Walking away from cancer: study tests if exercise lowers recurrence risk

NCT ID NCT03975491

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looks at how moderate aerobic exercise (like brisk walking) might help prevent colorectal cancer from coming back. Researchers will measure changes in inflammation and other blood markers in 60 people who have finished cancer treatment. Participants either walk on a treadmill several times a week or continue their usual routine, and the study tracks biological changes over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
moderate-intensity aerobic exercise (treadmill walking)
What this could lead to
If successful, this could show that regular exercise after colorectal cancer treatment lowers inflammation and may reduce the chance of cancer coming back.
What could go wrong
This is a small, early-stage study (60 participants) looking at biological markers, not directly at cancer recurrence. Results may not prove exercise prevents recurrence, and individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLON CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana, 70808, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.